MorphoSys, Daiichi Sankyo to discover antibodies to treat nosocomial infections

MorphoSys AG said that it has reached an agreement with Daiichi Sankyo Company Ltd of Japan to discover and develop therapeutic antibodies to treat hospital-acquired infections. The financial terms were not disclosed.